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4Errata
The following corrections (underlined) have been made in the text: 
Page 8, paragraph 4, line 1: Hauge H, Movig T, Narvhus K…
Article IV, page 9, paragraph 2, last line: …than control cells (Fig. 6A).
Article IV, page 10, line 2: …cytometry (Fig. 6B).
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92. Introduction 
The human genome encodes ~30 0000 genes, and due to alternative splicing and post-
translational modifications they give rise to a much larger number of proteins with 
distinct functional properties. During development, pluripotent cells mature towards 
increasingly more committed cell lineages and the gene-expression programs become 
more defined and restricted. Different sets of genes are active in different cell types, 
tissues and organs, depending on the regulation by different combinations of transcription 
factors and epigenetic modifications (Reik, 2007). Because many genes and proteins have 
yet to be characterized, the study of genes and their protein products is important for 
understanding the biology of both normal and abnormal cells. During carcinogenesis, 
cells acquire mutations, deletions, and translocations that affect gene expression. Thus 
cells are selected that can escape the strict control they are normally placed under. The 
genetic aberrations seen in human cancers often affect cell cycle control, adhesion and 
migration, leading to increased proliferation, immortality and gain of invasive and 
metastatic potential. To identify and characterize tumor cells and improve cancer therapy, 
we need to define the changes in gene expression and to understand their functional 
effects.
2.1 Carcinogenesis 
Carcinogenesis is a multi-step process driven by changes in gene expression which 
disrupts the normal balance between proliferation and cell death, leading to uncontrolled 
cell growth and tumor formation (Hahn and Weinberg, 2002; Hanahan and Weinberg, 
2000). Cancer results from the accumulation of chromosomal alterations, gene mutations, 
and epigenetic changes that promote malignant growth. These changes include: autocrine 
production of growth factors, insensitivity to growth-inhibitory signals, evasion of 
apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and 
metastasis (Hanahan and Weinberg, 2000). The targeted genes are generally classified as 
proto-oncogenes when involved in the promotion of cell growth and survival, and tumor-
suppressor genes when involved in negative regulation of proliferation. Typically, a 
series of mutations in both proto-oncogenes and tumor-suppressor genes are required 
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before the signals for cell growth overwhelm the signals to regulate it, and a normal cell 
transforms into a cancer cell.  
The molecular basis of cancer has been the focus of intense investigation for many years. 
Although many molecular consequences of cellular transformation have been identified, 
we are just beginning to understand the events that lead to the neoplastic phenotype.
2.2 The cell-division cycle: Growth control and cancer
Normally, the balance between proliferation and programmed cell death is maintained by 
tightly regulating both processes to ensure the integrity of organs and tissues. Mutations 
that lead to cancer disrupt these orderly processes by disrupting growth control and have 
lead to the view of cancer as a cell cycle disease (Malumbres and Barbacid, 2001; 
Malumbres and Barbacid, 2007). 
Briefly, the cell cycle is divided into four distinct phases: the synthetic phase (S phase) 
where the chromosomes are duplicated; the mitotic phase (M phase) where the cell 
divides; and two gap phases (G1 and G2 phase) where the cell have additional time for 
growth and prepare the completion of S and M phases, respectively (Norbury and Nurse, 
1992) (Fig. 1). The G1, S, and G2 phases are collectively termed interphase, where the 
cell grows continuously. A mammalian cell has an average cycling time of about 24 
hours, and in most cells the whole M phase takes only about an hour. When cells cease 
proliferation, usually in response to a lack of growth factors or nutrients, they exit the cell 
cycle and enter a non-dividing, quiescent state known as G0. Although, cells can recover 
from G0 and enter the cycle in G1. Except for haematopoietic and epithelial cells most of 
the cells in the adult organism are quiescent, yet many tumor cells that undergo 
uncontrolled proliferation originate from such cells. 
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Figure 1. An overview of the cell-cycle control system. The core of the cell-cycle control system 
consists of a series of cyclin-Cdk complexes (yellow). The activity of each complex is also influenced 
by various inhibitory checkpoint mechanisms, which provide information about the extracellular 
environment, cell damage, and incomplete cell-cycle events (top) (Alberts et al., 2002).  
To ensure proper progression through the cell cycle, cells have developed a series of 
checkpoints that prevent them from entering into a new phase until they have 
successfully completed the previous one (Hartwell and Weinert, 1989) (Fig. 1). These 
surveillance mechanisms are based on an intricate network of protein kinases known as 
the cyclin-dependent kinases (Cdks) and their regulatory binding partners, the cyclins 
(Malumbres and Barbacid, 2005). Different cyclin-Cdk complexes are assembled and 
activated to control the mammalian cell cycle. Cdk4/6–cyclin D and Cdk3–cyclin C 
complexes regulate the G0–G1 transition and the early phases of G1 by phosphorylating 
the retinoblastoma protein (pRb). Cdk2–cyclin E complexes have been proposed to 
complete phosphorylation of pRb, an event that is thought to convey mitogenic 
independence to dividing cells. Cdk2–cyclin E complexes have also been implicated in 
the G1–S transition by licensing DNA origins of replication. Cdk2 later associates with 
cyclin A during progression through S phase. Cdk1 participates in the S–G2 and G2–M
transitions by sequential binding to cyclin A and cyclin B (Malumbres and Barbacid, 
2005).  It has been well established that deregulation of Cdks is one of the most frequent 
alterations in human cancer, leading to abnormal cell division and genomic instability 
(Malumbres and Barbacid, 2007). 
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The centrosome orchestrates the assembly and organization of the bipolar spindle during 
mitosis and is therefore a prerequisite for the maintenance of genetic stability (Kramer et 
al., 2003; Kramer et al., 2005). This organelle has also been shown to be involved in the 
coordination of cell-cycle progression by serving as a scaffold for anchoring of an 
extensive number of regulatory proteins, including several Cdks, cyclins and other cell-
cycle regulators (Doxsey et al., 2005b). Furthermore, the centrosome has been linked to 
the stress response mechanism and tumorigenesis (Andersen et al., 2003; Doxsey et al., 
2005b; Doxsey, 2001b; Fisk et al., 2002; Lange, 2002; Rieder et al., 2001; Sluder, 2005). 
The microtubule organizing center (MTOC) activity of the centrosome, that forms the 
interphase microtubule (MT) array and cilia, will be discussed in section 2.3.2. 
2.3 Adhesion and migration 
Most of the cells in multicellular organisms are organized into tissues, which in turn are 
organized in various combinations to form organs. The cells in tissues are usually in 
contact with a complex network of secreted extracellular macromolecules referred to as 
the extracellular matrix (ECM). The ECM holds cells and tissues together, through cell-
matrix adhesions, and provides an organized lattice within which cells can migrate and 
interact with one another by cell-cell adhesions. These adherens junctions are connected 
to the cytoskeleton of a cell through transmembrane linker proteins and intracellular 
attachment proteins that allows the cell to communicate with its surroundings. (Alberts et 
al., 2002) In response to internal and external signals cells rapidly alter their shape and 
behavior. These dynamic events require extensive remodeling of adhesive interactions as 
well as of the actin and MT cytoskeletons. During carcinogenesis, such remodeling can 
lead to loss of normal tissue architecture and proliferation control, whereby cells become 
motile and invasive (Yamazaki et al., 2005). 
2.3.1 The actin cytoskeleton 
The actin cytoskeleton is one of the major structural components of the cell and can be 
found in all kinds of eukaryotic cells, maintaining their shapes and motilities. It often 
undergoes rapid reorganization and plays crucial roles in a number of dynamic cellular 
processes including cell migration, cytokinesis, membrane trafficking, and 
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morphogenesis (Alberts et al., 2002). Actin subunits assemble into long filamentous 
polymers called F-actin where two parallel F-actin strands twist around each other in a 
helical formation, giving rise to the microfilaments of the cytoskeleton (Steinmetz et al., 
1997). In contrast to MTs that are anchored at the centrosome in the cytosol, actin 
nucleation occurs at the plasma membrane (Condeelis, 2001). Consequently, the highest 
density of actin filaments in most cells is at the cell periphery where they determine the 
shape and movement of the cell surface. Depending on their attachments to one another 
and to the plasma membrane, actin structures can form different types of cell surface 
projections. These include spiky bundles such as microvilli or filopodia, which are 
radially oriented fine bundles of actin filaments, flat protrusions called lamellipodia 
consisting of meshworks of branched actin filaments (Biyasheva et al., 2004), and 
contractile stress fibers that are linear actomyosin structures comprised of actin filaments 
of mixed polarity and myosin II (Cramer et al., 1997). 
Actin nucleation occurs through the coordinated activities of two major factors, Arp2/3 
and mDia. The Arp2/3 complex binds to the sides of pre-existing filaments and generate 
a branched network to promote membrane protrusion, like those found in lamellipodia 
(Condeelis, 2001). In contrast, mDia which belongs to the formin family of proteins, 
binds to the barbed ends of actin filaments where it nucleates linear unbranched actin 
filaments found in filopodia, stress fibers and cell adhesions (Goode and Eck, 2007). 
Cofilin is a protein also involved in the regulation of actin dynamics that severs actin 
filaments, leading to an increase in uncapped barbed ends that can serve both as sites of 
actin polymerization and actin monomer dissociation (Condeelis, 2001). The activities of 
all of these proteins are regulated by intracellular signaling molecules, the Rho GTPases, 
at the cytosolic face of the plasma membrane (Hall, 2005), as will be discussed further in 
section 2.3.5. 
2.3.2 The microtubule cytoskeleton 
The centrosome is the major MTOC of animal cells and directs the assembly of the 
interphase MT cytoskeleton, the mitotic spindle, primary cilia and cytokinesis (Doxsey, 
2001a). The centrosome consists of a pair of centrioles that is surrounded by the 
14
pericentriolar material comprised of more than 300 different proteins reported so far 
(Doxsey et al., 2005b). Nucleated at this organelle near the cell center and in close 
proximity to the nucleus, the interphase MTs emanate in a star-like conformation. MT 
polymers of α/β-tubulin heterodimers are anchored by their minus ends, and the plus 
ends point outward and grow toward the cell periphery (Doxsey, 2001a). While α- and β-
tubulins are the regular building blocks of MTs, another type of tubulin, called γ-tubulin
form a γ-tubulin ring complex (γ-TuRC) that nucleates a MT with 13 protofilaments 
forming the wall of this hollow polymer (Doxsey, 2001a). During interphase, the 
centrosome duplicates and splits into two daughter centrosomes. These two daughter 
centrosomes move to opposite sides of the nucleus at the start of mitosis, forming the two 
poles of the mitotic spindle that directs chromosome segregation and cytokinesis 
(Doxsey, 2001a).
Polarized epithelial cells also have an extensive non-centrosomal MT network, including 
the apico-basal array extending from the apical membrane, and a cortical MT network 
associated with the basal membrane. These MTs could be derived by nucleation and 
release from the centrosome (Mogensen, 1999). However, results from experiments with 
plants and fission yeast indicate that γ-tubulin-mediated MT nucleation is not restricted to 
the centrosome, but also occur at so called secondary MTOCs (Luders and Stearns, 
2007). γ-tubulin has been demonstrated to localize to the cortex of basal membrane 
patches, along cortical MTs and at MT branch points, and could serve to nucleate MTs at 
these sites (Reilein et al., 2005). 
Cilia are MT-based organelles evolutionarily related to the motile flagella of lower 
eukaryotes that project like antennae from the surface of most cells in the body (Marshall 
and Nonaka, 2006). A cilium arises from a basal body, a structure that differentiates from 
one of the centrioles in the centrosome in non-mitotic cells and organizes the MT bundles 
that constitute the ciliary axoneme (Sorokin, 1962). Primary cilia act as sensors of 
environmental cues and are essential sites for coordination of cell signaling and 
development (Marshall and Nonaka, 2006).  
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The interphase MTs are involved in cell polarization, migration, morphogenesis, cell 
signaling, and intracellular trafficking. These are all highly regulated processes and MT 
dynamics are consequently controlled both spatially and temporally by a diversity of MT-
associated proteins (Cassimeris, 1999). Several proteins have been identified which can 
stabilize and destabilize MTs and the balance between these accessory proteins is critical 
to cell fate. MTs are usually highly dynamic and undergo rapid turnover by exchange of 
subunits (t1/2 = 5-15 min) (Cassimeris, 1999). However, within the cytoplasmic network 
there also exists a stable subpopulation of MTs with increased half-life (t1/2 = 1-2 hr), 
which can be distinguished by a variety of posttranslational modifications (PTMs) 
(Verhey and Gaertig, 2007). These tubulin PTMs are suggested to dictate the recruitment 
of MT effectors like MT-associated proteins (MAPs), plus-end tracking proteins (+TIPs), 
and molecular motors, which contribute to MT stability and MT-based functions in 
specific cellular locations (Verhey and Gaertig, 2007).
Several actin regulatory proteins, like formins, myosins, and plakins have also been 
shown to be involved in the regulation of MT stability (Basu and Chang, 2007; Even-
Ram et al., 2007; Wen et al., 2004). Through interaction with both actin and  +TIPs such 
as end-binding protein 1 (EB1) and adenomatous polyposis coli (APC), actin regulatory 
proteins are capable of linking the dynamic plus ends of MTs to polymerizing ends of 
actin filaments and thereby contribute to the important interplay between the actin and 
MT cytoskeletons (Basu and Chang, 2007). In return, MT plus-ends have been shown to 
deliver formin and other actin regulatory proteins at the cell cortex to regulate actin 
assembly (Basu and Chang, 2007). This cross-talk between the MT and actin 
cytoskeletons at the cell periphery, where MTs provide directional cues for motility and 
help trigger local polymerization of actin networks, is necessary for proper regulation of 
membrane protrusion and cell migration (Palazzo and Gundersen, 2002).  
By changing their dynamics in response to signaling pathways, MTs themselves may 
contribute to signal transduction processes. This is suggested by the multiple effects of 
MT-stabilizing and -destabilizing drugs on signaling pathways, and by the discovery of 
signaling molecules, including phosphatases and kinases, that interact with MTs 
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(Gundersen and Cook, 1999). Mechanisms including MT sequestering and release, MT 
delivery, and MT scaffolding of signaling molecules could be involved in this MT-
mediated signal transduction (Gundersen and Cook, 1999). 
2.3.3 Cellular polarization 
Cellular polarization is a process mediated through asymmetric distribution of signaling 
molecules and the cytoskeleton, in addition to positioning of the endoplasmic reticulum 
(ER) and the Golgi apparatus, and directed membrane trafficking (Watanabe et al., 2005). 
Different types of cell polarity include the apical-basal polarity found in epithelial 
monolayers, the anterior-posterior polarity displayed by migrating cells, and T cell 
immunological synapse formation. However, cellular polarization is a functional aspect 
of almost every cell type (Nabi, 1999). In all cases the generation of cell polarity requires 
active remodeling of both the MT and actin cytoskeletons where actin polymerization 
drives membrane protrusion and generates motility and MTs are necessary for the 
polarization of these activities (Fig. 2).
Figure 2. Cell migration requires actin-dependent protrusions at the front (red) and contractile 
actin:myosin filaments (red) at the rear. In addition, microtubules (green) originating from the 
centrosome (purple) are preferentially stabilized in the direction of migration allowing targeted 
vesicle trafficking from the Golgi (brown) to the leading edge (Jaffe and Hall, 2005). 
An important aspect of MTs regarding cell polarization is that the filaments span the 
distance from the nucleus to the plasma membrane. With associated motor proteins 
moving back and forth, they provide a system for directional flow of information 
(Gundersen and Cook, 1999; Nabi, 1999). A resting cell receiving a signal from the 
environment to migrate reorients its MT array towards the direction of migration (Fig. 2). 
Here the plus ends are stabilized at the leading edge resulting in a polarized MT array 
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(Gundersen et al., 2004; Watanabe et al., 2005). MTs are guided along actin filaments by 
actin-based motor proteins, +TIPs and cytoskeletal cross-linking proteins, and are thereby 
targeted to cell-cell and cell-ECM adhesion sites (Fukata et al., 2002; Kodama et al., 
2003; Lantz and Miller, 1998). Once MTs and their associated proteins determine the 
polarity site, a positive feedback loop likely initiates where cortical polarity proteins 
anchor MT plus ends, and allows MTs to reinforce and maintain this polarity site 
(Siegrist and Doe, 2007). 
2.3.4 Adhesive interactions 
Cadherins and integrins are the major cell–cell and cell–extracellular matrix (ECM) 
adhesion receptors, respectively, and represent critical determinants of tissue architecture 
and function (Hynes, 2002; Wheelock and Johnson, 2003). 
Integrins are heterodimeric transmembrane glycoproteins composed of non-covalently 
linked α and β subunits, which are endowed with both structural and regulatory functions 
(Delon and Brown, 2007). They link the ECM to several distinct cytoplasmic proteins 
and the actin cytoskeleton at focal adhesion sites (Geiger et al., 2001). There they provide 
both outside-in and inside-out transmission of signals across the plasma membrane that 
control a number of critical cellular processes, including adhesion, migration, 
proliferation, differentiation, apoptosis, and gene expression (Hynes, 2002). Upon cell 
adhesion to ECM, integrin receptors become activated and cluster in the plasma 
membrane. The cytoplasmic domains then recruit over 50 structural and signaling 
proteins into a higher order complex termed focal adhesions (Miyamoto et al., 1995; 
Zamir and Geiger, 2001) (Fig. 3). These complexes provide the physical link between 
integrin receptors and the actin cytoskeleton, as well as sites of signal transduction into 
the cell (Zamir and Geiger, 2001). As actin polymerization drives membrane protrusion, 
focal adhesions are formed at the protruding edge allowing attachment of cells to the 
ECM and thereby generating a tractile force that cells use for locomotion (Carragher and 
Frame, 2004). The regulated turnover of focal adhesion complexes is also required for 
cell migration, since it allows release of the migrating cell to enable net forward 
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movement (Carragher and Frame, 2004). MT ends that target these sites have been shown 
to be implicated in the disassembly of focal adhesions (Ezratty et al., 2005). 
Figure 3. Upon cell adhesion to ECM, integrin receptors become activated and recruit structural and 
signaling proteins into a higher order complex termed focal adhesions. These complexes provide the 
physical link between integrin receptors and the cytoskeleton (Watanabe et al., 2005). 
Cadherins are single-pass transmembrane glycoproteins that support calcium-dependent, 
homophilic cell–cell adhesion (Halbleib and Nelson, 2006). Together with their 
cytoplasmic domain interactors, α-catenin and β-catenin, they constitute the core 
components of adherens junctions. These specialized adhesive structures link the 
cadherin homophilic adhesion to the actin cytoskeleton, and are required for formation 
and maintenance of stable cell–cell adhesion and a differentiated phenotype in all solid 
tissues (Wheelock and Johnson, 2003).  
2.3.5 Signaling pathways in adhesion and migration 
Cell adhesion and migration are essential processes not only during development, but 
throughout life such as in tissue organization, wound repair, and immune surveillance. 
The cell must be able to respond rapidly to changes in its external environment and re-
organize its actin and MT cytoskeltons to change shape and localization in response to 
signals from soluble factors or ECM. A huge variety of intracellular signaling molecules 
have been implicated in these processes, including Rho GTPases, phosphatidylinositol-3 
kinase (PI3K), mitogen-activated protein kinases (ERK/MAPK), protein kinase C (PKC), 
phospholipase C (PLC), and tyrosine kinases (Merlot and Firtel, 2003; Raftopoulou and 
Extracellular matrix
Microtubule +TIPs
Plasma membrane
Integrin
Focal adhesion
Myosin
Crosslinker
Actin
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Hall, 2004; Zhelev and Alteraifi, 2002). Moreover, the overall signaling of adhesion and 
motility is additionally complicated by significant cross-talk between the different 
pathways.
Rho GTPases belong to the Ras superfamily of small GTPases and are central in the 
control of cell behavior (Hall, 2005). They regulate and coordinate signal transduction 
pathways that link cell surface receptors to changes in the organization of the actin and 
MT cytoskeletons, in vesicular trafficking and in gene transcription (Raftopoulou and 
Hall, 2004). Rho GTPases act as molecular switches by cycling between a GDP-bound, 
inactive form and a GTP-bound, active form. The Rho GTPase cycle is regulated by 
guanine nucleotide exchange factors (GEFs) that promote the exchange of GDP for GTP, 
GTPase activating proteins (GAPs) that stimulate GTP hydrolysis, and guanine 
nucleotide exchange inhibitors (GDIs) that sequester the GDP-bound form from 
membranes (Etienne-Manneville and Hall, 2002; Raftopoulou and Hall, 2004). In their 
GTP-bound state, Rho GTPases interact with cellular target proteins to generate a 
downstream response (Bishop and Hall, 2000).
During cell spreading, a series of morphological changes transpire when studying the 
actin cytoskeleton; Rho induces the assembly of actin stress fibers and focal complexes at 
the cell periphery; Rac controls the formation of lamellipodia, and Cdc42 triggers the 
formation of filopodia. Both types of membrane protrusions can occur simultaneously, 
and both play a role in migration (Hall, 2005). Recent studies have shown that Rho 
GTPases also regulate the dynamics of MTs through effectors which interact with +TIPs 
and MAPs (Watanabe et al., 2005). In turn, MTs affect the activities of Rho GTPases, 
apparently through modulation of the activity of GEFs (Siegrist and Doe, 2007; 
Watanabe et al., 2005; Wittmann and Waterman-Storer, 2001), and thereby influence on 
actin polymerization. 
The different organization of actin filaments in lamellipodia and filopodia suggests that 
these membrane protrusions are formed by different molecular mechanisms triggered by 
separate pathways. The paradigm has been that protrusion of lamellipodia and filopodia 
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is regulated by two parallel pathways: from Rac through Scar/WAVEs to lamellipodia, 
and from Cdc42 through N-WASP to filopodia (Faix and Rottner, 2006). Although, it has 
been suggested that neither Rac nor Cdc42 are indispensable as several of the 22 
mammalian Rho-GTPases have been described to induce both lamellipodia and filopodia 
(Aspenstrom et al., 2004). Furthermore, it appears that in many of the studied systems 
filopodia emerge from lamellipodia, suggesting that the lamellipodium serves as a 
precursor structure (Biyasheva et al., 2004; Svitkina et al., 2003).
Both integrins and cadherins have been shown to activate Rho GTPases (Braga and Yap, 
2005; Hall, 2005). In this way Rho GTPases could participate in the coordinated 
modulation of the cellular functions of these adhesion receptors which is essential to 
morphogenesis, tissue differentiation and renewal, wound healing, immune surveillance, 
and tumor progression (Retta et al., 2006). 
2.4 B-cell non-Hodgkin’s lymphomas 
B-cell non-Hodgkin’s lymphomas (B-NHL) are malignant tumors that arise from mature 
B lymphocytes. NHL accounts for approximately 4% of all new diagnosed cancers in 
Western countries, and lymphomas of B cell origin constitute about 85% of all NHLs. 
The remainders arise from T lymphocytes. The B lymphocytes constitute the humoral 
antibody response of the immune defense and secrete antibody molecules, or 
immunoglobulins (Igs), in the circulation that bind specifically to non-self antigens 
(Janeway et al., 2004). These antibodies, which are secreted forms of the membrane-
bound B-cell receptor (BCR), inactivates the infectious agent by preventing the binding 
to receptors on host cells and marks it for destruction by other components of the immune 
system (Janeway et al., 2004). A hallmark of many types of B-cell lymphoma is 
reciprocal chromosomal translocations involving one of the Ig loci and a proto-oncogene 
(Kuppers, 2005). As a consequence of such translocations, the oncogene comes under the 
control of an active Ig locus, causing deregulated, constitutive expression of the 
translocated gene (Kuppers, 2005). Thus, key transforming events rely on processes that 
are crucial for normal B-cell development and are also the basis for determination of the 
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origin of the various human B-cell lymphomas (Kuppers et al., 1999; Stevenson et al., 
2001).
Early B-cell development takes place in the bone marrow and concludes when a 
functional and non-autoreactive BCR is expressed on the surface. This development 
includes site-specific genetic recombination of Ig genes (V(D)J recombination) which is 
the basis for the huge antibody repertoire and ensures that any given non-self antigen can 
be recognized (Jung and Alt, 2004). These distinct gene rearrangements also equip each 
B cell with individual clonal markers that constitute an important basis for the analysis of 
B-cell lymphomas. Mature, naïve B cells leave the bone marrow and enter the circulation. 
Upon encounter with their specific antigen, B cells become activated and collect in the 
germinal centers (GCs) of secondary lymphoid organs including, lymph nodes, spleen 
and mucosa-associated lymphoid tissue (MALT). In the GCs, the Ig genes of antigen-
activated B cells are modified by somatic hypermutation. As a result, some B cells 
produce antibodies with increased affinity towards the antigen and undergo clonal 
expansion. Furthermore, class switch recombination alters the effector functions that the 
antibody can engage (Janeway et al., 2004). The process of somatic hypermutation is 
~106 times greater than the spontaneous mutation rate in other genes. Altogether, the 
means by which antibody diversity is generated both in the bone marrow and the GCs, 
involving DNA double strand breaks, jeopardize the DNA integrity of the developing B 
cells and are important factors for lymphoma pathogenesis (Kuppers, 2005). 
B-NHLs constitute a heterogenous group of tumors. This heterogeneity is also reflected 
in clinical outcome and response to treatment. In the current WHO classification, 
lymphomas are grouped according to morphology, immunophenotype, and genetic and 
clinical features (Harris et al., 2000). The aim is to create homogenous subgroups in order 
to optimize the treatment and improve clinical outcome. About 15 different types of B-
NHL have been defined according to the WHO classification (Harris et al., 2000). When 
assigned to their proposed normal B-cell counterparts determined by the mutational status 
of the Ig genes, most lymphomas are derived from GC B cells (ongoing somatic 
hypermutation) or from B cells that have passed through the GC (completed 
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hypermutation) (Kuppers, 2005) (Fig. 4). The two largest lymphoma subtypes are 
follicular lymphoma (FL) (~20%) and diffuse large B-cell lymphoma (DLBCL) (~30-
40%).
Figure 4. Assignment of human B-cell lymphomas to their normal B-cell counterparts (Kuppers et 
al., 1999). 
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2.4.1 Follicular lymphoma 
Although, FL starts as a relatively indolent malignancy with a median survival of 8-9 
years, they are generally incurable. 10-60% of FLs transform to the more aggressive form 
DLBCL, often accompanied by less than one years survival (Knutsen, 1997; Lossos and 
Levy, 2003; Sigal et al., 2005). Transformation is characterized by loss of the follicular 
histological architecture reminiscent of normal GCs, to a diffuse growth pattern (Fig. 5).
Figure 5. Patient matched biopsies of FL and histologically transformed DLBCL. FLs 
morphologically recapitulate normal germinal centers of secondary lymphoid follicles while DLBCLs 
are characterized by a diffuse proliferation of large cells with a high mitotic rate. 
That FL derives from normal GC B cells is further supported by the observation that they 
show a pattern of ongoing somatic hypermutation and display a characteristic GC B cell 
gene-expression signature (Alizadeh et al., 2000; Harris et al., 1994; Shaffer et al., 2001). 
The initiating genetic event found in the majority of FLs is the t(14;18)(q32;q21) 
chromosomal translocation resulting in constitutive expression of the anti-apoptotic BCL-
2 gene and accumulation of cells with prolonged survival (McDonnell et al., 1989). 
However, the finding that BCL-2 transgenic mice do not readily develop lymphoma 
(McDonnell et al., 1989; McDonnell and Korsmeyer, 1991; Strasser et al., 1993) and that 
B cells containing a t(14;18) can normally be present in healthy human individuals 
(Limpens et al., 1995; Liu et al., 1994), demonstrate that additional oncogenic mutations 
need to accumulate to cause FL. The exact secondary alterations leading to full FL 
development are still poorly defined (Bende et al., 2006). 
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2.4.2 Diffuse large B-cell lymphoma 
Histologically, DLBCL is characterized by large transformed B cells with a diffuse 
growth pattern and a high proliferation fraction (Fig. 5). DLBCL comprises a highly 
heterogeneous group of neoplasms with different genetic abnormalities and clinical 
features, and several different morphological variants of DLBCL have been defined 
according to the WHO classification (Harris et al., 2000). DLBCL can arise as a 
consequence of histological transformation of primary FL and accordingly retain the 
t(14;18), but most commonly DLBCL occurs as de novo DLBCL. Genetic alterations 
frequently observed in DLBCL are associated to BCL-2, BCL-6, TP53, and cMYC 
genes, affecting regulation of apoptosis, cell cycle control and proliferation (Gascoyne et 
al., 1997; Ichikawa et al., 1997; Lossos et al., 2002; Ye et al., 1993). Some of these 
alterations correlate with clinical outcomes. However, they do not accurately reflect the 
heterogeneous clinical courses and responses to therapy (Fisher et al., 1993; Vose, 1998).
Improvements in molecular tumor classification have been essential to the advances seen 
in cancer treatment. Historically, the classification of cancer types has been primarily 
based upon morphological appearance of the tumor. The limitation of this approach is 
that tumors with similar histopathological appearance can display different clinical 
courses and responses to therapy (Golub et al., 1999). It is now recognized that tumors 
with common behavior (phenotype) has a common gene expression signature, and that 
classification of tumors based upon their molecular signatures is much more useful for 
predicting patient outcome and response to therapy than morphological characterization 
(Chung et al., 2002). As a consequence, DNA microarray technology and gene 
expression profiling has provided important insights into the biology of DLBCL. 
Microarray analyses have revealed that DLBCL can be divided into three subtypes based 
on the expression of a set of sixteen genes (Alizadeh et al., 2000; Rosenwald et al., 2002). 
These three subtypes include GC-like DLBCL, activated B cell (ABC) -like DLBCL, and 
a mixed subtype lacking high expression of either the GC- or the ABC-defining genes 
(type III). The ABC-like subtype is suggested to originate from post GC cells on the basis 
of the gene expression pattern and concluded somatic hypermutation (Rosenwald et al., 
2002). The subtypes were shown to have significantly different outcomes with 60% alive 
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at 5 years in GC-like DLBCL compared with only 35% in ABC-like DLBCL and  39% in 
type III (Alizadeh et al., 2000; Rosenwald et al., 2002). The major differences between 
GC-like DLBCL and ABC-like DLBCL are summarized in table 1.  
 GC-like DLBCL ABC-like DLBCL 
Ongoing Ig mutations Present Absent 
Cytogenetics t(14;18)(q32;q21) Trisomy 3 
 Amplification of c-rel locus on 
chromosome 2p 
3q and 18q21-22 gains 
 12q12 gain 6q21-22 loss 
Oncogenic mechanisms BCL-6 expression Constitutive activation of NF-kB 
Blimp-1 Low mRNA expression High mRNA expression 
  Lack of protein expression 
Intracellular signaling cAMP modulates pAKT and 
pBAD 
PDE4B inactivates cAMP 
 Normal IL-4-induced STAT6 
signaling 
Aberrant IL-4-induced STAT6 signaling 
due to increase STAT6 dephosphorylation 
Clinical Outcome Favorable Poor 
 60% 5-year survival 35% 5-year survival 
Table 1.    Differences between GC-like DLBCL and ABC-like DLBCL (Morgensztern et al., 2007).
These studies on the global gene expression of DLBCLs further highlight the 
heterogeneity of this type of lymphoma and the need for molecular diagnosis to design 
individualized and molecularly targeted therapies. 
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3. Aims of the present study 
1. To identify and characterize novel genes differentially expressed in patient-
matched biopsies of low-grade follicular and high-grade diffuse large B-cell 
lymphoma using cDNA Representational Difference Analysis (cDNA RDA).  
2. To identify molecular mechanisms potentially associated with histological 
transformation and thereby increase the understanding of disease progression. 
3. To consider the application of identified genes in diagnostics and therapy. 
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4. Summary of included publications 
Article I: Characterization of a novel immunoglobulin-like domain containing 
receptor.
We employed cDNA RDA on a patient matched pair of clonally related FL and 
histological transformed diffuse large B-cell lymphoma (DLBCL) for the selection of 
DLBCL related transcripts. One of the identified cDNA RDA fragments was selected for 
further characterization due to its homology to a predicted surface receptor and 
hybridization to cDNA fragments of different sizes in the FL and DLBCL 
representations, which could indicate the expression of different alternatively spliced 
transcripts in the two disease states. Cloning and characterization of three splice variants 
revealed the existence of two membrane-spanning and one cytoplasmic isoform of the 
gene. An N-terminal immunoglobulin-like domain was identified in all three isoforms, 
and the gene was therefore denoted immunoglobulin-like domain containing receptor 1 
(ILDR1). ILDR1 expression could be detected in prostate, pancreas, kidney, testis, liver, 
and heart. Cellular localization showed that the two isoforms containing a predicted 
transmembrane domain located to the cell membrane. The third isoform lacking this 
domain localized to the cytosol. An ILDR1 homologue, rat lipolysis-stimulated remnant 
receptor (LSR), with 31% amino acid identity was identified by database search. Three 
isoforms of LSR are identified that heteromerize to either to a trimeric or a tetrameric 
plasma membrane receptor (Yen et al., 1999). LSR is proposed to bind lipoproteins and 
to be involved in the clearance of dietary triglycerides from the circulation. The overall 
resemblance in splice pattern and organization of motifs, in addition to protein analyses, 
suggests that ILDR1 might also form heteromers. To this end, we have not identified a 
ligand for ILDR1. Interestingly, we observed that the expression pattern of ILDR1 
isoforms was altered after transformation in five out of six paired lymphoma biopsies 
examined. In addition, the cytoplasmic isoform was only detected in lymphoma samples 
and not in any of the normal tissues or cell lines investigated. Our results could suggest 
that ILDR1 expression and function is altered during tumor progression. 
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Article II: Identification of a novel centrosome/microtubule-associated coiled-coil 
protein involved in cell-cycle progression and spindle organization. 
In this study we applied cDNA RDA on a patient matched pair of clonally unrelated FL 
and DLBCL for the selection of DLBCL related transcripts. One of the identified cDNA 
RDA fragments was selected for further characterization due to a reported higher gene 
expression of a related cDNA fragment in DLBCL than in FL (Alizadeh et al., 2000) and 
its induced expression in activated B cells. Cloning and characterization of the gene 
product of this gene, denoted centrosome/spindle pole-associated protein (CSPP1),
revealed that CSPP is expressed in human testis in addition to all cell lines examined. 
This could indicate a proliferation related association. CSPP is a serine phosphorylated 
coiled-coil protein that localizes to centrosomes and microtubules, and induces the 
formation of aberrant, predominantly multipolar, spindles and aneuploidy upon over-
expression. CSPP over-expression is also characterized by a block in the G1 and M phase 
of the cell cycle. Interestingly, CSPP depletion by short interfering RNA impaired cell 
cycle progression through S phase. This phenotype was characterized by elevated levels 
of cyclin A, decreased levels of cyclin E, and phosphorylation of the S-phase checkpoint 
kinase Chk 1. Activation of Chk1 could reflect a replication stress-response due to 
compromised DNA replication. Finally, in silico examination of CSPP expression in a 
microarray dataset comprising 240 DLBCLs (Rosenwald et al., 2002) indicates that 
CSPP over-expression correlates to poor prognosis in the activated B cell lymphoma 
subtype of DLBCL. Altogether, this report indicates that CSPP is functionally associated 
with cell-cycle related and cytoskeletal processes and that deregulated CSPP expression 
might be related to cancer progression.
Article III: Characterization of the FAM110 gene family. 
In a yeast two-hybrid screen for CSPP-interacting proteins, we identified the open 
reading frame (ORF) C20orf55. The corresponding protein was selected for further study 
due to an observed co-localization with CSPP in initial screening studies. GenBank 
homology search revealed that C20orf55 belongs to a not yet described gene family, 
consisting of three members that we set out to characterize. The ORFs of these genes 
were cloned and denoted family with sequence similarity 110 (FAM110), member A 
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(C20orf55), B, and C as suggested by the HUGO Nomenclature Committee. Except from 
a proline-rich stretch, no known conserved domains or homology to other characterized 
proteins were identified. Although, three distinct motifs highly conserved in all three 
protein members could represent functional motifs characteristic to this family. 
Expression of FAM110A was detected in several tissues, including peripheral blood 
leukocytes and other lymphoid tissues. In addition, FAM110A expression was induced 
upon stimulation of CD4+ lymphocytes and also increased in S and G2/M phase of the 
cell cycle relative to G1 phase. FAM110B and FAM110C expression, on the other hand 
was detected mainly in tissues other than lymphoid tissues. Studies in transfectants 
showed that the FAM110 proteins localized to centrosomes and accumulated at the 
microtubule organizing center (MTOC) in interphase and at spindle poles in mitosis. 
Interestingly, FAM110C also localized to the microtubule cytoskeleton throughout the 
cell cycle, and induced microtubule aberrancies upon over-expression. Furthermore, all 
three FAM110 proteins co-localized with CSPP at the MTOC and mitotic spindle, 
although yeast two-hybrid analysis only indicated binding of FAM110A to CSPP. Cell 
cycle analysis showed that expression of FAM110B and FAM110C impaired progression 
through G1 phase. Altogether, in this study we identified and initially characterized a 
novel protein family where all members localize to the centrosome and spindle poles. The 
data presented suggest that FAM110 homologues are functionally associated to cell-cycle 
related processes and to CSPP, but also indicate that they are differentially regulated and 
have somewhat different functional properties.  
Article IV: FAM110C involved in the crosstalk between the cytoskeleton and Akt 
signaling; a role in cell spreading and migration. 
Due to the explicit phenotype induced upon FAM110C over-expression (article III), 
displaying an aberrant MT cytoskeleton, we decided to further investigate its function. In 
this manuscript we show that FAM110C is expressed mainly in adherent cells of 
epithelial origin. Together with our previous observation, this suggested the possibility 
that FAM110C is involved in events characteristic to cells with an adherent phenotype, 
such as cell adhesion, spreading and migration. A potential role for FAM110C in these 
cellular processes was therefore investigated. We present data showing that depletion of 
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FAM110C reduced integrin-mediated filopodia formation, HGF-induced migration, and 
Akt activation in the epithelial cell line HepG2. Furthermore, ectopically expressed 
FAM110C co-precipitated and co-localized with Akt1 and the actin-cytoskeleton 
organizer ezrin. In particular, co-localization and biochemical studies indicated an 
interaction between active Akt1 and FAM110C. We also show that FAM110C binds to 
and stabilizes MTs, demonstrated by increased acetylation levels and resistance towards 
the MT-depolymerizing drug nocodazol. These results provide the first evidence for a 
role of FAM110C in adhesion and migration, and suggest that FAM110C could couple 
the actin and MT cytoskeletons at the cell cortex promoting membrane protrusion, cell 
adhesion, and migration events in an Akt-dependent fashion. 
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5. General discussion
5.1 Methodological considerations
5.1.1 Expression analysis: General aspects 
Because different sets of genes are active in different cell types, tissues, and organs an 
important approach to gain knowledge about biological processes or the function of 
genes, is to perform gene expression analyses. Traditionally, measurement of gene 
expression has been performed at a single target level, but the development of different 
high throughput technologies now allows functional genome-wide analysis. The methods 
used for analysis in this study comprise both strategies and include Northern blot 
analysis, semi-quantitative reverse-transcription PCR (RT-PCR), real-time PCR, and 
cDNA RDA. Northern blot analysis is a classical method for quantitative analysis of gene 
expression. By this method various characteristics of mRNA can be examined including 
mRNA abundance and mRNA size. The limitations of Northern blot analysis relates to 
the need for relatively large amounts of RNA and the fairly slow and labor-intensive 
methodology. Following the development of PCR, a number of amplification-based 
applications for gene expression analysis have emerged. The most common of these is 
RT-PCR, a method based on amplification of target sequences contained within a cDNA 
population. RT-PCR is rapid, extremely sensitive and specific, and requires very little 
template RNA. Real-time PCR has become the more frequently used version of this 
technique, because in addition to all the advantages of RT-PCR real-time PCR also 
features a quantitative output and an automated process. RT-PCR and real-time PCR are 
employed to assess the expression of specific genes, but are of limited value in a study 
aimed at gene discovery. Here differential display technologies such as cDNA RDA can 
be employed. This method will be discussed in detail in the next section. There are 
several important aspects regarding gene expression analysis that are common for all the 
different technologies:
• The experimental data obtained are dependent on the quality of the RNA 
preparations. Thus the proper handling of cells and tissues is crucial for reliable 
comparison of independent samples. 
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• The specificity of the assay relies on complementarities in the sequences of probe 
and target and is influenced by the stringency of the hybridization. 
• The experimental data obtained may be influenced by cellular heterogeneity. 
• To compare gene expression levels between different samples, the amount and 
quality of the RNA put into the experiment needs to be normalized. In addition, it 
is common to relate the expression of the genes of interest to that of a 
housekeeping gene such as β-actin, GAPDH, or PGK1 that is supposedly 
expressed at a steady level. 
5.1.2 cDNA Representational Difference analysis 
The initial basis for our studies was to use cDNA Representational Difference Analysis 
(cDNA RDA) to detect gene expression differences between two cDNA populations, 
represented by different stages of disease. RDA is a method that employs subsequent 
rounds of PCR amplification coupled to subtraction and was originally developed to 
identify the differences between two complex genomes (Lisitsyn et al., 1993). The 
methodology was later modified for the analysis of cDNA and is based on the elimination 
of fragments present in both populations, leaving only the differences (Hubank and 
Schatz, 1994). Briefly, the procedure relies on generation of representations of cDNA 
fragments from two different mRNA populations by digestion with the four-cutting 
enzyme DpnII followed by linker ligation and PCR amplification (Fig. 6A). A restriction 
site theoretically present for every 256 base pairs in a random sequence ensures that the 
majority of cDNA species will contain at least one amplifiable fragment, which is 
sufficient to isolate a difference and identify the gene. As a consequence, cDNAs with 
less than two restriction sites are not amplified by the protocol and will not be detected by 
cDNA RDA even if highly differentially expressed. The amplified representation from 
which uniquely expressed genes are to be identified is termed “tester”, which in our study 
was the DLBCL samples, and the “driver” is used to subtract commonly expressed genes, 
which was the FL samples. The protocol utilized in this study makes use of biotinylated 
primers and streptavidin coated paramagnetic beads for solid phase purification (kindly 
provided by Dr. Joakim Lundeberg), which makes the technology suited for analysis of 
small tissue samples (Odeberg et al., 2000). 
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The generated representations are subjected to three iterative steps of subtractive cross-
hybridization and selective PCR amplification of tester specific fragments. This is 
possible because prior to each round linkers from the preceding PCR amplification step 
are removed, and new linkers ligated to the tester representation only. As a consequence, 
driver homoduplexes are not amplified, driver/tester heteroduplexes are amplified 
linearily, whereas tester homoduplexes are amplified exponentially (Fig 6B). Linear 
amplified, single-stranded cDNA is digested by mung bean nuclease. Each round 
generates a difference product (DP1, DP2, and DP3) and the selective pressure is 
enhanced in subsequent rounds by increasing the tester: driver ratio from 1:100 (DP1), to 
1:800 (DP2), and finally 1:400 000. The enrichment of tester specific cDNA fragments is 
visualized by a stepwise reduction in complexity of the difference products and 
amplification of individual bands in each successive round (Fig. 6C). Shot-gun cloning of 
purified cDNA fragment bands followed by sequencing shows that these bands typically 
contain more than one cDNA species.  
One of the main advantages of cDNA RDA is that only a low amount of starting material 
is required due to the initial PCR amplification step. About 300 μg of driver 
representation and 20 μg of tester representation are required to complete three rounds of 
subtractive hybridization and amplification. It is critical to titrate the number of PCR 
amplification cycles of the digested double stranded cDNA and the amount of template in 
the initial PCR amplification step to avoid biased amplification of shorter fragments. 
There has not been reported any problems with selection of “false-positives” (non-
differentially expressed genes) by cDNA RDA. Although, we and others noticed that a 
large portion of the identified sequences were not present in human expressed sequence 
tag databases (est-dbs, NCBI Blast, Ensembl) (Andersson et al., 2002; Borang et al., 
2001; Frohme et al., 2000; Odeberg et al., 2000). This is probably due to two reasons: 
First, est-db entries are mostly cDNAs partially sequenced from either 5´or 3´, whereas 
the selected DpnII fragments mostly represent central parts of the cDNA. Second, the 
high stringency (tester/driver ratio 1:400 000 in DP3) and the power of PCR 
amplification selects for differentially expressed low abundance transcripts. Some of the 
limitations of cDNA RDA are that it is unlikely to identify differences due to point 
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mutations, very small deletions and insertions. Fragments from the ends of transcripts or 
fragments which lack appropriate enzyme sites remain undetected. On the other hand it is 
well suited for the identification of alternatively spliced transcripts and also holds the 
possibility of identifying yet undescribed gene transcripts. 
Figure 6. cDNA Representational Difference Analysis. (A) Schematic presentation of the principal 
steps of cDNA RDA (Odeberg et al., 2000). (B) Due to tester-specific linkers only tester 
homoduplexes are amplified exponentially, whereas driver/tester heteroduplexes are amplified 
linearily, and driver homoduplexes are not amplified. Linear amplified, single-stranded cDNA is 
removed by nuclease digestion. As a consequence, after several rounds of subtractive hybrization and 
amplification, fragments present in both tester and driver are eliminated and tester-specific genes 
are enriched. (C) Southern blot of difference products (DP) obtained after each round of subtractive 
hybridization and amplification hybridized with a DP3 probe. Tester (DLBCL) specific fragments 
are enriched already after the second round.  
Important to note is that high-throughput array-based molecular technologies have been 
developed that in combination with bioinformatics-based data mining strategies enable 
multiple parallel experiments to be conducted through largely automated processes. This 
is essential in developing gene biomarkers that can be used in therapy, diagnosis, and 
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prognosis. cDNA RDA could be performed in combination with array analyses to assess 
the validity and generality of findings generated by this technique. Although less 
encompassing than microarray analysis, RDA is an established method to identify 
differentially expressed genes in similar tissue types. Unlike array-based technologies, 
RDA offers the advantage of being able to detect any sequence or gene, not just the ones 
embedded onto the arrays. 
In summary, cDNA RDA has been shown to be a powerful technique for the detection of 
gene expression differences between two populations, also from uncharacterized genes. It 
requires very low amounts of starting material and due to the sensitivity cDNA RDA is 
able to isolate genes expressed in only a very small fraction of cells from which the tester 
is derived. However, because of the high sensitivity care must be taken in the generation 
of representations and validation of obtained difference products.
5.1.3 The cell systems 
In this study cell lines have been used to study the expression, localization, and biological 
effects of ectopically expressed proteins (article I-IV) in addition to siRNA-mediated 
gene silencing (article II and IV). Furthermore, expression analyses have been performed 
on cells from normal tissue (article I-III) and lymphoid tumors (article I and II). The use 
of cell lines has four main advantages: first, the amount of cells and thus RNA and 
protein is not a limiting factor; second, the cell population is relatively homogenous; 
third, manipulation of gene expression is feasible; and fourth, there is generally a 
profound knowledge available about genotype, phenotype and behavior in different 
experimental settings. Clearly, special care should be taken when using cell lines as 
model systems for functional studies. After many years of ex vivo cultivation many of the 
characteristics of the in vivo situation may have been lost and multiple mutations may 
have been acquired. In addition, stable cell lines are often derived from tumor cells with 
genetic aberrations. The functional outcome of protein over-expression or depletion is 
dependent on the whole gene expression pattern of the cell, which also can be affected by 
the presence of serum and the lack of a natural environment during in vitro cultivation. 
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Therefore, all expression data and functional results should ultimately be confirmed by 
the use of primary cells or in vivo e.g. by the use of transgenic mice.  
To summarize, it is important to have in mind the pitfalls of each of the different cell 
systems when evaluating the experimental data. One also needs to be careful not to 
extrapolate conclusions drawn from experiments in one system to another. However, 
functional results from cell line studies are valuable for the generation of hypotheses, 
which subsequently can be tested in primary cells of normal or malignant origin. 
5.1.4 siRNA technology 
Knowledge about the expression and regulation of a given gene is important when 
hypothesizing its function; however gene silencing followed by investigation of the 
cellular phenotype is a central tool in functional characterization. Discovery of the RNA 
interference (RNAi) pathway, which allows systematic suppression of gene expression in 
mammalian cells, has greatly facilitated loss of function studies (Elbashir et al., 2001). 
RNAi was originally identified in plants, fungi, and worms where it protects the genome 
from viruses and other insertable genetic elements and regulates gene expression during 
development (Fire et al., 1998; Jorgensen, 1990; Romano and Macino, 1992).  
In this study we have utilized chemically synthesized double stranded short interference 
RNAs (siRNAs). Once introduced within cells, the siRNAs are unwound by a 
multiprotein RNA-inducing silencing complex (RISC) in an ATP-dependent process, and 
the antisense strand directs recognition of the target mRNA sequences (Fig. 7) (Hannon 
and Rossi, 2004). The mRNA homologous to the introduced siRNA is cleaved at a single 
site and then subsequently degraded, resulting in a loss of gene function (Hannon and 
Rossi, 2004). The small size of the molecules (21-23 nucleotides) enables robust and 
consistent transfection, although the transfection requirement limits this technology to 
transfectable cell lines. A drawback is also that gene suppression will occur transiently, 
limiting assay phenotypes to those that occur over the course of a few days. Furthermore, 
siRNAs are relatively stable molecules but cell division will gradually dilute siRNAs. 
Although, with the advent of vector-mediated siRNA delivery methods it is now possible 
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to make transgenic animals that can silence gene expression stably without the production 
of knockout mice through homologous recombination (Dykxhoorn et al., 2003). An 
additional factor that can influence siRNA-mediated silencing is the half-life of the 
protein. To promote efficient gene silencing consideration of the target sequence is a 
crucial but empirical process, as the rules that govern efficient siRNA directed silencing 
are still largely unknown (Dykxhoorn et al., 2003). As a consequence of this, siRNAs 
targeting different sites in the gene of interest should be synthesized and validated 
(Dykxhoorn et al., 2003). To avoid off-target effects, a BLAST search of the selected 
sequence should be performed against sequence databases such as est-dbs, NCBI Blast, 
or Ensembl. If the same phenotype is observed after introduction of two different 
siRNAs, then the off-target effects should also be minimized.  
Figure 7. The short interfering RNA (siRNA) pathway. siRNAs are incorporated into the RNA-
inducing silencing complex (RISC) and unwound in an ATP-dependent process. The single-stranded 
antisense strand guides RISC to mRNA that has a complementary sequence, which results in the 
cleavage of the the target mRNA (Dykxhoorn et al., 2003). 
In summary, gene silencing using RNAi has become an effective and frequently 
employed approach for the analysis and understanding of gene function, which also holds 
the promise for the development of therapeutic gene silencing (Sioud, 2004).
siRNA duplex
siRNA –protein complex (siRNP)
siRNA-mediated target recognition
RISC activation
mRNA cleavage
mRNA
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5.2 cDNA RDA on lymphoma biopsies 
Our experimental setup was to enrich cDNAs preferentially expressed in DLBCL using 
cDNA RDA by subtraction between DLBCL and FL. cDNA RDA was performed on two 
sets of patient matched biopsies of FL and DLBCL. Only tissue that was left over from 
diagnosis was used for research. Patient I was initially diagnosed with FL carrying the 
t(14;18) BCL-2 translocation and two years later diagnosed with clonally related DLBCL 
characterized by structural abnormalities involving chromosome 5 and 9 in addition to 
the original t(14;18) translocation. Patient II was initially diagnosed with FL carrying the 
BCL-2 translocation and five years later diagnosed with clonally unrelated DLBCL with 
a deletion on chromosome 6q, but no t(14;18) translocation (secondary de novo DLBCL). 
Del 6q has been related to aggressive DLBCL with short survival times (Whang-Peng et 
al., 1995). These two patients thus represent two independent ways of progression.
Total RNA was isolated from twenty 50 μm tissue sections. In the case of FL, malignant 
B cell containing follicles accounted for approximately 30% of the tissue, whereas 
DLBCL almost exclusively consisted of malignant B cells. DLBCL specific genes should 
therefore be representatives of genes whose expression is associated with disease 
progression but not with the initial disease development. 95 gene fragments were 
identified and 80% were evaluated by Southern blot analyses to be differentially 
expressed in the initial FL and DLBCL representations, that is expressed in the DLBCL, 
and not, or to a lesser degree in the FL. The fact that no gene fragments were identified in 
both transformed and secondary de novo DLBCL could indicate that for the most part 
different genes are involved in the transformation process of clonally related versus 
clonally unrelated transformed follicular lymphoma. This is also suggested after 
comparison of the gene-expression patterns of 12 transformed DLBCLs with those of 11 
de novo DLBCL specimens (Lossos et al., 2002), and further underlines that similar 
phenotypical appearance can be reflected through different gene programs.  
Several of the identified genes have previously been related to cancer development, such 
as H-prune (Marino and Zollo, 2007), cytochrome c oxidase I (COXI) (Tarantul and 
Hunsmann, 2001), arylsulphatase A (Omer et al., 1994; Turkmen et al., 2001), thymosin 
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β4 (Chen et al., 2005a), ATP2A2 (Chung et al., 2006; Korosec et al., 2006), and 
thymidine kinase (Broët et al., 2001; Di Raimondo et al., 2001; Hallek et al., 1992). The 
human homologue of the Drosophila gene PRUNE has been correlated with cancer 
metastasis and cell motility and has been shown to be amplified (1q21) in a variety of 
human cancers including DLBCL (Martinez-Climent et al., 2003; Palanisamy et al., 
2002). H-prune would therefore be an interesting candidate to study further in 
histologically transformed lymphomas. In addition, a large number of the sequences 
identified were poorly characterized genes that should be the subject of further studies.
To investigate if any of the identified gene fragments could be related to disease 
progression in general, the intention was to array the identified cDNA clones, together 
with other known lymphoma-related cDNAs, on glass-slides and perform microarray-
based profiling of an extended series of paired biopsy samples. This could not be 
performed due to difficulties in slide preparation at that time. In addition, several 
laboratories reported on gene expression analyses of lymphoma biopsies (Alizadeh et al., 
2000; Lossos et al., 2002; Rosenwald et al., 2002). We therefore decided to perform 
candidate gene studies. Thus two gene fragments were selected for further investigation: 
the first from patient I (later denoted ILDR1 (article I)) and the second from patient II 
(later denoted CSPP1 (article II)). 
In summary, cDNA RDA has proved to be a robust technique for identification of 
differently expressed genes in lymphoma biopsies as evaluated by Southern blot analysis. 
Among these, there are several potentially interesting genes related to carcinogenesis but 
also a large number of uncharacterized genes that should be further explored. 
5.3 Identification and expression of ILDR1 
In article I, we characterized a novel gene denoted ILDR1. Three transcribed splice 
variants of this gene were identified. Sequence analyses and cellular localization data 
indicated that two of the variants encode cell membrane-spanning isoforms, and the third 
variant a cytosolic isoform. Western blot analysis and immunofluoresence microscopy of 
ectopically expressed isoforms, together with the sequence homology to a rat lipolysis-
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stimulated remnant receptor (LSR) (Yen et al., 1999), suggest that these proteins hold an 
intrinsic ability of forming heteromeric complexes. This would be possible to further 
investigate by co-precipitation analyses. 
The membrane-associated isoforms are predicted to expose an immunoglobulin-like (Ig-
like) domain on the cell surface. Ig-like domain containing proteins form one of the 
largest superfamilies in vertebrates and are involved in many different kinds of 
interactions (Barclay, 2003) where the Ig-like domain appears to be involved in binding 
functions. The overall structural resemblance with LSR prompted the investigation of 
lipoproteins as ligands for ILDR1 (data not shown). Due to the lack of an appropriate 
positive control, our experiments could not conclude on this.  
Semi-quantitative RT-PCR analysis did not show association for any of the isoforms to 
histological transformation which was the initial aim of the study, but interestingly, the 
samples investigated suggested that the cytoplasmic isoform might be a FL/DLBCL-
specific variant. The expression of this isoform could be involved in modulating 
extracellular ligand binding. Alternative splicing of pre-mRNA is a process leading to the 
production of distinct protein isoforms, which may have entirely novel functional 
properties or even dominant negative or antagonistic functions. The two main 
mechanisms that lead to splicing defects in cancer are mutations in cis-splicing regulatory 
elements and changes in trans-splicing factors affecting the splicing machinery (Faustino 
and Cooper, 2003). Normally, inappropriately spliced forms are eliminated by the 
nonsense-mediated mRNA decay (NMD) pathway (Culbertson, 1999), but in some 
pathological conditions aberrant mRNAs escape this quality control mechanism. For 
many genes, dramatic changes in alternative splicing patterns are associated with 
neoplasia and metastasis (Nissim-Rafinia and Kerem, 2002; Pajares et al., 2007; Philips 
and Cooper, 2000). The gene products are often regulators of apoptosis, hormones, and 
receptors mediating cell-cell and cell-matrix interactions, and confer a selective 
advantage to cells housing the changes. Altered splicing patterns can also provide 
diagnostic and prognostic information and serve as markers for disease even when they 
are not in the primary pathway of the disease mechanism (Pettigrew and Brown, 2008).  
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Importantly, due to the limited number of samples investigated for expression of ILDR1 
isoforms so far, a larger panel of FL/DLBCL biopsies, cell lines and tissues should be 
explored. To evaluate the potential as a tumor marker, other neoplasms should also be 
investigated. In addition, its functional role should be determined. 
5.4 Identification and expression of CSPP1 
In article II, a novel coiled-coil protein denoted centrosome/spindle pole-associated 
protein (CSPP) was characterized. Initial in silico expression analysis suggested  a 
correlation of CSPP1 expression and DLBCL, while expression was low in FL (Alizadeh 
et al., 2000). This expression pattern could simply reflect the high proliferation rate in 
high-grade disease or, alternatively, contribute to disease progression. The observed 
aneuploidy upon prolonged CSPP over-expression could be in favor of the last 
assumption and suggests that CSPP expression could partially account for abnormal 
mitosis, and chromosome and centrosome aberrations reported in DLBCL (Bloomfield et 
al., 1983; Johansson et al., 1995; Knutsen, 1997; Kramer et al., 2003; Kramer et al., 2005; 
Tilly et al., 1994).
We show that CSPP is associated with centrosomes and MTs and may play a role in 
G1/S-phase progression and spindle assembly. Subcellular localization data and cell-cycle 
analyses are based on ectopic expression of CSPP in transfectants. Upon evaluation of 
experimental data from over-expression studies, it is important to keep in mind that the 
protein of interest will be expressed throughout the cell cycle. This may force protein 
activity at a stage where it is normally inactivated or absent, or in a context where 
regulatory mechanisms might be different from the normal situation. In addition, over-
expression can lead to artificial localization and sequestration of interacting proteins. 
Because ectopic CSPP forms aggregates at high expression levels, as also reported for 
other coiled-coil domain containing proteins (Andersen et al., 2003), the analysis of cells 
showing low ectopic expression levels should be emphasized. However, even 
experimental results at aberrant expression levels are valuable for the generation of 
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hypotheses, which subsequently can be tested by siRNA-mediated protein depletion or 
antibodies to characterize endogenous proteins. 
Cell-cycle analyses showed that ectopic expression of CSPP blocked cell-cycle 
progression in G1 phase and in mitosis, even at relatively low expression levels. 
Furthermore, CSPP-depletion induced cell-cycle arrest/delay in S phase. A relevant 
question raised is how a protein can affect progression through three different cell cycle 
stages? Firstly, during interphase, CSPP associates with MTs and mainly accumulates at 
and around centrosomes, while in mitosis localization is mainly conferred to the spindle 
poles of aberrant mitotic spindles and their kinetochore MTs. The impaired mitotic 
progression was characterized by the appearance of multipolar spindles in ~70% of CSPP 
expressing mitotic cells. This might be explained by a CSPP-associated (minus-end) MT 
bundling activity which could be mediated by the coiled-coil mid domain. Supporting 
this are data showing that CSPP-L, a larger isoform of CSPP, which mainly induces the 
formation of monopolar and bipolar spindles, has a 51 amino acids insertion in this 
domain that might abrogate MT bundling (Patzke et al., 2006). Indeed, the deletion of 
this insertion from CSPP-L increases the percentage of multipolar spindles, and 
expression of isolated MT binding/organizing domains of CSPP and CSPP-L differently 
affect MT organization. Strikingly, among CSPP-expressing mitotic cells normal 
metaphase plate alignment of chromosomes were rarely seen. The predominantly 
observed phenotype was characterized by condensed chromosomes aligned in ring-like 
structures around multiple spindle poles. The spindle checkpoint monitors the status of 
kinetochore-MT attachments and prevents cells from progressing to anaphase until all 
kinetochores are properly attached to MTs (Musacchio and Salmon, 2007). Based on the 
assumption that CSPP over-expression disturbs normal spindle assembly, the observed 
mitotic arrest could be due to activation of the spindle checkpoint. Other studies have 
also shown that ectopic expression of MT-associated proteins leads to MT-bundling and 
mitotic cell-cycle arrest. TMAP/CKAP2 is a protein frequently up-regulated in various 
malignancies and expression of a nondegradable mutant increase the occurrence of 
spindle defects and cytokinesis failure (Hong et al., 2007). NuSAP is another example  of 
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a protein that induce MT bundling, spindle deficiency, and mitotic arrest upon over-
expression (Li et al., 2007). 
Secondly, the hypothesis based on our results is that CSPP is involved in a G1/S
checkpoint preventing premature entry into S phase. Then, lack of CSPP could allow 
premature entry into S-phase, which might lead to activation of the DNA replication 
checkpoint shown by the activation of Chk1 (Machida and Dutta, 2005). This might also 
explain the G1 block observed upon over-expression that prevents S-phase entry. Several 
studies have established a role for the centrosome organelle in the regulation of G1-to-S-
phase progression (Doxsey et al., 2005a; Doxsey et al., 2005b; Mikule et al., 2007; 
Sluder, 2005; Srsen et al., 2006). Indeed, depletion of centrosomal proteins in p53 
deficient cell lines induces mitotic aberrancies similar to what is observed upon CSPP 
over-expression (Mikule et al., 2007). Thus, sequestration of such proteins by CSPP 
could contribute to the observed phenotype. Further support of a role for CSPP in G1-
phase checkpoint control comes from a report showing that upon knockdown of the 
transcription factor Miz1, a protein involved in the control of G1 arrest in response to 
DNA damage, cells failed to up-regulate CSPP1 expression (Wanzel et al., 2005). 
Importantly, characterization of the CSPP-L isoform (Patzke et al., 2006) showed that the 
siRNA used to deplete CSPP in article II also targets CSPP-L. We can therefore not 
conclude if the observed defect in S-phase progression is due to CSPP or CSPP-L 
depletion, or both. This paper also shows that CSPP expression peaks in the G1 phase of 
the cell cycle (Patzke et al., 2006) and suggests that the observed CSPP-induced mitotic 
block upon over-expression could be due to forced protein expression at a stage where it 
is normally present at a reduced level. A CSPP1-specific antibody recognizing both 
isoforms has been developed and characterization of endogenous CSPP has been initiated 
(Patzke, S., personal communication). So far, preliminary data confirm the centrosomal 
and midbody localization (Patzke et al., 2006) of CSPP1 isoforms. Furthermore, 
localization to the basal body and parts of the MT axoneme of non-motile primary cilia 
has been unraveled (Patzke, S., personal communication). This is the subject of further 
studies.
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5.5 Identification and expression of a new gene family, FAM110 
In article III and IV we describe the characterization of the family with sequence 
similarity 110 (FAM110), member A, B, and C. As discussed in the previous section, 
precaution when evaluating experimental data from over-expression studies has to be 
taken. This study was initiated to explore potential CSPP-interaction partners with the 
purpose of adding further insight to the role of CSPP. In addition, the FAM110 family of 
proteins was subjected to further characterization due to the specific subcellular 
localization patterns and phenotypes induced both upon over-expression and depletion. 
A cDNA clone corresponding to FAM110A was first identified in a yeast two-hybrid 
analysis where the first 360 amino acids (aa) of CSPP were used as bait to screen a 
peripheral blood lymphocyte (PBL) library. Further, homology search identified 
FAM110B and FAM110C, harboring 31% and 26% aa identity to FAM110A, 
respectively. In article III expression analyses showed that FAM110A is broadly 
expressed in human tissues, including lymphoid tissues and further analyses in article IV 
indicated that FAM110C is expressed foremost in adherent cell lines of epithelial origin. 
The FAM110 family displays no homology to other previously characterized proteins or 
protein domains. However, three sequence elements in addition to a proline-rich region 
are highly conserved among the members, which could indicate functional motifs 
characteristic to the FAM110 family. These motifs should be dissected further to 
understand the role of and identify interaction partners for these proteins. Despite of the 
structural similarities, expression patterns suggests that the FAM110 homologues are 
differentially regulated which could indicate that they harbor somewhat different 
functional properties.
A liquid β-Gal assay in yeast indicated that FAM110A and CSPP are able to interact, 
which was further supported by co-localization in transiently transfected HEK293T cells. 
Although co-localization could be observed also with FAM110B and FAM110C, these 
homologues did not show any significant binding to CSPP in the liquid assay. FAM110A 
contains a unique proline-rich region, and such sequence elements are often involved in 
protein-protein interactions. To explore the contribution of this motif in the potential 
45
CSPP-interaction, two FAM110A deletion constructs were generated. In the first, the 
proline-rich region was removed (aa 136-146, GenBank Accession No. DQ431181) and 
in the second, the first sequence element, the SAVERLEAD-motif, common to all 
homologues was deleted (aa 41-51). A liquid β-Gal assay showed that none of the 
FAM110A mutants longer bound to CSPP (data not shown). This could either indicate 
that the globular structure of the protein was obstructed and a potential conformational 
epitope disintegrated, or that both motifs are important for the interaction. In any case, 
this did not elucidate the potential FAM110A-CSPP interaction any further. However, it 
would be interesting to study the subcellular localization of the mutant lacking the 
SAVERLEAD-motif to explore whether this sequence element could be involved in the 
centrosome/spindle pole localization of FAM110 members. Furthermore, an 
immunoprecipitation-approach of tagged proteins from lysate of co-transfectants could 
not detect a putative FAM110A-CSPP interaction (data not shown). Since studies on co-
transfected HEK293T cells showed that FAM110A and CSPP co-localized only at the 
MTOC, we speculate that there could be a conformational change induced in one or both 
of the proteins at this site that allows binding and that this interaction “drowns” in the 
excess amounts of protein produced in the cell. We can of course not rule out that these 
proteins do not interact directly but are linked through a common protein complex. This 
might be elucidated when antibodies are available to study endogenous proteins. 
To identify potential FAM110A-interacting proteins, a further yeast two-hybrid analysis 
was performed. RGS14 was one of three clones identified (data not shown) that might be 
of particular interest because it is a MT-associated protein and a component of the mitotic 
spindle that may regulate MT polymerization and spindle organization (Martin-
McCaffrey et al., 2005). RGS14 is thereby involved in processes that CSPP and FAM110 
proteins also seem to be implicated in. 
In many aspects FAM110C has more features in common with CSPP than FAM110A. 
Both are expressed in testis, localize to centrosomes and MTs, and induce G1-phase arrest 
upon ectopic expression. Like CSPP, exposure of transiently transfected HEK293T cells 
to the MT depolymerizing drug nocodazole indicates MT-independent association of 
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FAM110C with centrosomes (data not shown). Proteins that localize to centrosomes 
independently of a nucleated MT array, like γ-tubulin and pericentrin, are generally 
considered as “core” centrosomal components (Oegema et al., 1995).  
The mechanism causing the FAM110C induced G1-phase arrest could be the result of 
bundling of interphase MTs which could abrogate the rapid turnover of MTs necessary 
for mitotic entry (Cassimeris, 1999). It has been shown that a critical balance between 
MT stabilizers and MT destabilizers is necessary for assembly of the mitotic spindle 
(Cassimeris, 1999) and this balance might be pushed upon over-expression of FAM110C. 
Furthermore, several other MT-associated proteins than FAM110C and CSPP have been 
shown to affect G1-phase transition like CDC14B, Ckap2, RASSF1A, and RGS14 (Cho 
et al., 2005; Liu et al., 2003; Martin-McCaffrey et al., 2005; Rong et al., 2004; 
Shivakumar et al., 2002; Tsuchihara et al., 2005). We also observed that adherent 
HEK293T cells expressing high levels of ectopic FAM110C rounded up and lost their 
natural morphology. Integrin-mediated adhesion has been demonstrated to be critical to 
cell-cycle progression through G1-phase (Assoian and Schwartz, 2001; Danen and 
Yamada, 2001; Schwartz and Assoian, 2001), so disruption of these contacts could be 
involved in the observed arrest as well. It should be investigated if also the expression of 
FAM110C is cell-cycle phase dependent, like it is for FAM110A and CSPP, which could 
give indications on when the protein is most essential to the cell. To further characterize 
the endogenous protein a FAM110C-specific polyclonal antibody has been developed 
and studies have been initiated. 
5.6 FAM110C in cell adhesion and migration 
Due to the explicit phenotype induced upon FAM110C over-expression, we decided to 
pursue the characterization of this particular member of the FAM110 family of proteins 
in article IV. Our data indicate that FAM110C is a protein expressed predominantly in 
cells of epithelial origin. We show that filopodial formation and cell spreading is 
abrogated upon FAM110C-knockdown and that FAM110C depletion alters the migratory 
potential of the epithelial cell line HepG2. Furthermore, the activation of Akt upon 
integrin-mediated adhesion is almost completely abolished compared to controls. Akt has 
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been demonstrated in several studies to be central in filopodia formation and cell motility 
(Enomoto et al., 2005; Higuchi et al., 2001; Kim et al., 2001; Qian et al., 2004), 
suggesting that FAM110C promotes membrane protrusion through activation of Akt. 
Additionally supportive for this is that FAM110C co-precipitates and co-localizes with 
Akt1. These experiments also suggested that FAM110C interacts with active Akt1. A 
predicted Akt substrate recognition motif in FAM110C suggested that Akt in turn could 
exert influence on FAM110C. Indeed, immunoprecipitation data indicated that mutation 
of the putative threonine phosphorylation target affects the interaction between Akt1 and 
FAM110C. To establish whether FAM110C is a true target of Akt phosphorylation and to 
identify the functional implications of this modification will be important in the further 
characterization of FAM110C. Phosphorylation could potentially affect the MT-binding 
properties of FAM110C, as well as its subcellular localization and interaction with other 
proteins as suggested for other MT-associated proteins (Berti et al., 2004; Cassimeris, 
1999; Rong et al., 2004). 
In addition, the results indicate that ectopically expressed FAM110C co-localizes with 
acetylated MTs, a marker of stabilized MTs, and also increase the level of stabilized MTs 
compared to controls. However, the exact mechanism by which FAM110C enhance MT 
stability is not clear. Notably, there are studies showing that MT-stabilization is important 
for membrane protrusion and migration (Even-Ram et al., 2007; Mikhailov and 
Gundersen, 1998; Palazzo et al., 2004; Wen et al., 2004) and MT acetylation in particular 
has been proposed to have a role in cell motility. A recent report suggested that the 
reduced migratory potential of cells where the tubulin deacetylase HDAC6 was inhibited 
could be due to decreased MT-dynamics and focal adhesion turnover (Tran et al., 2007). 
In that respect it is interesting to note that CSPP-L contains a putative HDAC interaction 
domain in its N-terminus and co-precipitates with HDAC6 (Patzke, S., personal 
communication). It is thereby tempting to speculate that FAM110C and CSPP are part of 
a protein complex that could regulate the activity of HDAC6 and thereby affect MT-
stability. Further it has been shown that Akt can promote MT-stabilization in migrating 
cells (Onishi et al., 2007) and that HDAC6 inhibitors and HDAC6 depletion suppress Akt 
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phosphorylation and induce MT acetylation (Bali et al., 2005; Chen et al., 2005b; Fiskus 
et al., 2007). 
The data presented indicate that FAM110C harbors several properties to mediate 
filopodia formation: first, the ability to affect MT stabilization; second, to facilitate 
activation or recruit activated Akt; and third, to crosslink the actin and MT cytoskeletons 
at the cell membrane via ezrin. In summary, FAM110C could serve to bring together 
structural and signaling components important for cell adhesion and migration.  
Interestingly, in the panel of carcinoma cell lines investigated the level of FAM110C 
expression is low or absent in HeLa and SKBR-3 that are E-cadherin negative cells. 
Cadherins are transmembrane proteins that mediate cell-cell adhesion through homotypic 
interaction and linkage to the actin cytoskeleton via intracellular catenins (Provost and 
Rimm, 1999). Down-modulation of E-cadherin expression and reduction of cell contacts 
is a key event during carcinoma progression leading to increased invasive and metastatic 
potential (Birchmeier and Behrens, 1994; Vleminckx et al., 1991). Provided that there is 
a coordinated downmodulation of E-cadherin and FAM110C expression in invasive 
carcinomas to escape from their original tissues, a potential function for FAM110C in 
cell-cell adhesion should be investigated.
The results indicate that FAM110C is involved in filopodia formation and migration. To 
further elucidate the biological function of FAM110C and the mechanisms involved, a 
microarray study and real-time PCR analysis has been performed on FAM110C-depleted 
HepG2 cells. Notably, a significant number of the genes affected are involved in 
cytoskeleton organization, cell adhesion, and cell motility. Furthermore, two proteins that 
can negatively regulate the PI3K-pathway (p85alpha and PIPP) (Geering et al., 2007; 
Ooms et al., 2006) are upregulated in the expression analyses. Considering the observed 
lack of activated Akt in FAM110C-knockdown cells upon integrin-mediated adhesion, 
this should be investigated further. 
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6. Conclusions 
• The use of cDNA RDA on patient matched biopsies of FL and DLBCL has 
proven valuable for the identification of novel genes whose expression is 
potentially associated with DLBCL. Two previously undescribed genes have been 
identified and characterized during the course of our study: the immunoglobulin-
like domain containing receptor 1 gene (ILDR1) and the centrosome/spindle pole-
associated protein 1 gene (CSPP1).
• The ILDR1 gene encodes three isoforms, of which two are cell-membrane 
spanning and one is cytosolic, and might assemble into a multimeric receptor. The 
cytosolic isoform was found to be expressed only in the lymphoma samples and 
not in normal tissue or cell lines investigated. This might be due to aberrant 
splicing in lymphoma cells which could modulate extracellular ligand binding and 
could potentially serve as a marker for disease. Both the receptor ligand and 
biological function remains at present elusive. 
• The CSPP1 gene encodes a centrosome/microtubule associated protein that 
appears to be temporally expressed through the cell cycle and affect cell cycle 
progression and MT organization in mitosis. Over-expression of CSPP has been 
correlated to high-grade DLBCL by gene expression analysis (Alizadeh et al., 
2000). An oncogenic role of CSPP is further supported by that over-expression of 
CSPP disturbs normal spindle assembly and promotes multipolar spindles. 
• The characterization of CSPP1 led to the discovery of three undescribed 
homologous genes constituting the family with sequence identity 110 (FAM110),
member A, B, and C. The three members are to some extent expressed in the 
same tissues but FAM110A is expressed also in lymphoid tissues and peripheral 
blood leukocytes, while FAM110C is expressed predominantly in epithelial 
tissues. FAM110 proteins localize at the MTOC in interphase and at spindle poles 
in mitosis, where they also co-localize with CSPP. In addition, FAM110C localize 
to the MT-cytoskeleton throughout the cell cycle and induce MT aberrancies upon 
over-expression, which may also induce the observed G1-phase arrest. FAM110C 
depletion indicates that this homologue is involved in Akt-dependent filopodia 
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formation and MT stabilization in epithelial cells, and supports a role for 
FAM110C in cell adhesion and migration. 
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7. Perspectives 
The importance of ILDR1 expression should be further explored with main focus on the 
identification of a potential ligand and the cell type specific expression of the individual 
isoforms. 
A CSPP-specific monoclonal antibody has been developed and characterization of 
endogenous CSPP has been initiated. In addition to confirm a centrosomal localization, 
preliminary data has shown that CSPP localize to the basal body of non-motile primary 
cilia (Patzke, S., personal communication). This should also be investigated in relation to 
FAM110 homologues. Experiments to explore the nature of the cell cycle arrests and the 
role of CSPP in MT organization and mitosis are also initiated. The identification of 
protein interaction partners and kinases involved in CSPP phosphorylation will be of 
importance. 
A FAM110C-specific polyclonal antibody has been developed and the characterization of 
endogenous FAM110C expression in different cell types has been initiated. Our focus 
will be to investigate the cellular localization of FAM110C and participation in filopodia-
formation. In relation to this, the potential phosphorylation by Akt will be important to 
examine. We will validate the binding to Akt and the cytoskeleton-membrane organizer 
ezrin, and also seek to identify additional protein interaction partners to further explore 
the function of FAM110C. Furthermore, microarray- and real-time PCR data indicating 
an effect of FAM110C-depletion on the expression of several proteins involved in 
cytoskeletal organization and membrane ruffling should be further examined. 
Identification of the mechanism behind the MT-stabilizing effect of FAM110C will be 
pursued and a potential link to the deacetylase HDAC6 will be investigated. It should 
also be considered if targeting FAM110C expression could have therapeutic applications 
in treatment of invasive and metastatic tumors. 
To develop antibodies recognizing FAM110A and FAM110B, and further characterize 
these homologues will be a subject of future studies. The potential binding of FAM110A 
to the MT-associated protein RGS14 identified in a yeast two-hybrid screen will be 
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pursued. The expression of FAM110A in leukocytes and lymphoid tissues could 
potentially be interesting with regard to cytoskeletal organization and polarization events 
taking place during leukocyte activation, signaling, and migration, especially in light of 
the observed increased FAM110A expression upon stimulation of resting CD4+
lymphocytes.  
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